Abstract

Background: There are various treatment modalities for atherosclerotic arterial obstructive disease at the lower limbs, for example, conservative physical therapy, medication, operation etc. Yet it has been established that an arterial bypass operation is the most effective treatment. The aim of this study is to evaluate the effect of arterial bypass operation within our experience and to determine the indicators of treatment. Material and Method: Ninety six patients received arterial bypass operation for atherosclerotic arterial obstructive disease from June 2002 to April 2006. We evaluated the feasibility of arterial bypass operation based on the improvement of symptoms and the ankle-brachial index (ABI) and the surgical outcomes, as based on the complications, the amputation rates and the patency rates. We also assessed the possible risk factors such as gender, age, a smoking history, co-morbidities, the anastomotic sites, the graft size and the graft type. We retrospectively reviewed the medical records of the patients. The total mean follow-up period was $29.4{\pm}13.1$ months. Result: The mean age was $65.95{\pm}9.61$ and there were 88 male patients. The most common clinical manifestation was ischemic resting pain in the lower extremities. The underlying combined diseases were hypertension (61%), diabetes (43%), cardiac problems (35%) and smoking (91.7%). The most frequent site of arterial obstruction was the superficial femoral artery (44 cases, 40%). A femoropopliteal artery bypass operation with a Polytetrafluoroethylene(PTFE) synthetic graft was done in 44 cases (40%) and the great saphenous vein graft was used in 11 cases. The postoperative ABI increased significantly from $0.30{\pm}0.11$ preoperatively to $0.63{\pm}0.11$ (p<0.001) postoperatively. In 8 cases, amputations above the ankle level were necessary. The graft patency rates were 86.4% and 68.0% after 1 and 3 years, respectively. There were 29 cases (30.21%) of patency failure; the male gender, smokers and hypertension were significantly more frequent in the failure group. Of these, hypertension was the most powerful risk factor (p=0.042). Conclusion: The arterial bypass operation is an effective treatment modality for controlling the symptoms such as pain and claudication, and for preventing major amputations for the patients with atherosclerotic arterial obstructive disease. This study suggests quitting smoking, strict blood pressure control, selection of an appropriate graft, regular outpatient follow up and proper medication would offer higher patency rates and more favorable outcomes.

Keywords

• Atherosclerosis;
• Peripheral vascular disease;
• Revascularization;
• Vascular surgery

• 동맥경화;
• 말초혈관질환;
• 혈관재통;
• 혈관수술;

File

Download PDF

References

1. Schmieder FA, Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Am J Cardiology 2001;87(suppl):3-13D
2. Bloor K. Natural history of atherosclerosis of the lower extremities. Ann R Coll Surg 1961;28:36-51
3. TransAtlantic InterSociety Consensus (TASC) Working Group. Managenent of peripheral arterial disease (PAD). J Vasc Surg 2000;31:S5-44, S54-74, S77-122 https://doi.org/10.1016/S0741-5214(00)81003-4
4. Choi JY, Son MS, Lee KY, et al. Long-term follow up results of nonoperative treatment for critical lower extremity ischemia. J Korean Soc Vasc Surg 2003;19:32-8
5. Plecha EJ, Freischlag JA, Seabrook GR, Towne JB. Femoro-popliteal bypass revisited: an analysis of 138 cases. Cardiovasc Surg 1996;2:195-9
6. Dormandy JA, Murray GD. The fate of the claudication: a prospective study of 1969 claudicants. Eur J Vasc Surg 1991;5:131-3 https://doi.org/10.1016/S0950-821X(05)80676-0
7. Kim WY, Kim HT, Park JM, et al. Results of infrainguinal chronic arterial occlusion - difference in medical and surgical management. J Korean Soc Vasc Surg 2002;18:61-7
8. Pappas PJ, hobson RW II, Meyers MG, et al. Patency of infrainguinal polytetrafluoroethylene bypass grafts with distal interposition vein cuffs. Cardiovasc Surg 1998;2:19-26
9. Woratyla SP, Darling RC 3rd, Chang BB, et al. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee. Am J Surg 1997;174:169-72 https://doi.org/10.1016/S0002-9610(97)90077-5
10. Green RM, Abbott WA, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: five year results of a randomized trial. J Vasc Surg 2000;31:417-25 https://doi.org/10.1016/S0741-5214(00)90300-8
11. Mii S, Mori A, Sakata H, Kawazoe N. Fifteen-year experience in axillofemoral bypass with externally surpported knitted Dacron prosthesis in a Japanese hospital. J Am coll Surg 1998;186:581-8 https://doi.org/10.1016/S1072-7515(98)00084-2
12. Jamal J, Hoballah M, Nazzal MS, et al. Is color duplex surveillance of infra-inguinal polytetrafluoroethylene graft worthwhile? Am J Surg 1997;174:131-5 https://doi.org/10.1016/S0002-9610(97)90070-2
13. Fujioka K, Esato K, Zempo N. Effective of elastase on primary graft patency after femoropopliteal arterial bypass for arteriosclerosis obliterances: a randomized, controlled study. Int Surg 1997;82:94-7